Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in china

Heart Lung and Circulation

Volumn 23, Issue 9, 2014, Pages 818-826

  Liu, Xiaoyan ^a   Yu, Haiyun ^a   Pei, Juanhui ^a   Chu, Jianmin ^a   Pu, Jielin ^a   Zhang, Shu ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Chronic heart failure; Dilated cardiomyopathy; Ischaemic cardiomyopathy; Prognosis; Treatment

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; WARFARIN; MINERALOCORTICOID ANTAGONIST;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHINA; CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; SUDDEN CARDIAC DEATH; AGED; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; DEATH, SUDDEN, CARDIAC; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PRESCRIPTION; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TIME; VENTRICULAR FIBRILLATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; CHINA; CHRONIC DISEASE; COMORBIDITY; CREATININE; DEATH, SUDDEN, CARDIAC; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 84923814254     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.02.022     Document Type: Article

References (30)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013, 127(1):e6-e245.
2. Kimura H., Hiramitsu S., Miyagishima K., Mori K., Yoda R., Kato S., et al. Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure. Heart Vessels. 2010, 25(4):306-312.
3. Sakata Y., Shimokawa H. Epidemiology of heart failure in Asia. Circ J. 2013, 77(9):2209-2217.
4. Loehr L.R., Rosamond W.D., Chang P.P., Folsom A.R., Chambless L.E. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008, 101(7):1016-1022.
5. Linde C., Daubert C. Cardiac resynchronization therapy in patients with New York Heart Association class I and II heart failure: an approach to 2010. Circulation 2010, 122(10):1037-1043.
6. Jiang H., Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China. Heart 2009, 95(21):1727-1731.
7. Bui A.L., Horwich T.B., Fonarow G.C. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011, 8(1):30-41.
8. Mosterd A., Hoes A.W. Clinical epidemiology of heart failure. Heart 2007, 93(9):1137-1146.
9. Pecini R., Moller D.V., Torp-Pedersen C., Hassager C., Kober L. Heart failure etiology impacts survival of patients with heart failure. Int J Cardiol. 2011, 149(2):211-215.
10. Pei J., Li N., Chen J., Li X., Zhang Y., Wang Z., et al. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure. Eur J Heart Fail 2012, 14(8):887-894.
11. Fatkin D. Guidelines for the diagnosis and management of familial dilated cardiomyopathy. Heart Lung Circ 2007, 16(1):19-21.
12. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006, 48(5):e247-e346.
13. Bueno H., Ross J.S., Wang Y., Chen J., Vidan M.T., Normand S.L., et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA. 2010, 303(21):2141-2147.
14. Haeck M.L., Hoogslag G.E., Rodrigo S.F., Atsma D.E., Klautz R.J., van der Wall E.E., et al. Treatment options in end-stage heart failure: where to go from here?. Neth Heart J. 2012, 20(4):167-175.
15. Levy D., Kenchaiah S., Larson M.G., Benjamin E.J., Kupka M.J., Ho K.K., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002, 347(18):1397-1402.
16. Bleumink G.S., Knetsch A.M., Sturkenboom M.C., Straus S.M., Hofman A., Deckers J.W., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004, 25(18):1614-1619.
17. Goldberg R.J., Ciampa J., Lessard D., Meyer T.E., Spencer F.A. Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med. 2007, 167(5):490-496.
18. Adabag S., Smith L.G., Anand I.S., Berger A.K., Luepker R.V. Sudden cardiac death in heart failure patients with preserved ejection fraction. J Card Fail. 2012, 18(10):749-754.
19. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Bohm M., Dickstein K., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012, 14(8):803-869.
20. Cao Y.M., Hu D.Y., Wang H.Y., Wu Y. A survey of medical therapies for chronic heart failure in primary hospitals in China. Zhonghua Nei Ke Za Zhi. 2006, 45(11):907-909.
21. Steinberg B.A., Zhao X., Heidenreich P.A., Peterson E.D., Bhatt D.L., Cannon C.P., et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 2012, 126(1):65-75.
22. Al C.M. Traditional Heart Failure Medications and Sudden Cardiac Death Prevention: A Review. J Cardiovasc Pharmacol Ther 2013, 18(5):412-426.
23. Wang JQ, Wu GR, Wang Z, Dai XP, Li XR. Long-term Clinical Outcomes of Statin Use for Chronic Heart Failure: A Meta-analysis of 15 Prospective Studies. Heart Lung Circ. 2013. [Epub ahead of print].
24. Strabuzynska-Migaj E., Szyszka A., Cieslinski A. Prolonged QRS duration in patients with heart failure: relation to exercise tolerance, diastolic function and aetiology. Kardiol Pol. 2008, 66(12):1251-1257.
25. Hasan A., Yancy C.W. Treatment of ventricular dysrhythmias and sudden cardiac death: a guideline-based approach for patients with chronic left ventricular dysfunction. Congest Heart Fail. 2007, 13(4):228-235.
26. Gami A.S., Olson E.J., Shen W.K., Wright R.S., Ballman K.V., Hodge D.O., et al. Obstructive Sleep Apnea and the Risk of Sudden Cardiac Death: A Longitudinal Study of 10,701 Adults. J Am Coll Cardiol. 2013, 62(7):610-616.
27. Andrey J.L., Romero S., Garcia-Egido A., Escobar M.A., Corzo R., Garcia-Dominguez G., et al. Mortality and morbidity of heart failure treated with digoxin. A propensity-matched study. Int J Clin Pract. 2011, 65(12):1250-1258.
28. Joshi K., Alam I., Ruden E., Gradus-Pizlo I., Mahenthiran J., Kamalesh M., et al. Effect of improvement in left ventricular ejection fraction on long-term survival in revascularized patients with ischaemic left ventricular systolic dysfunction. Eur J Echocardiogr. 2011, 12(6):454-460.
29. Pop D., Penciu O.M., Sitar-Taut A.V., Zdrenghea D.T. Comparative heart failure profile over a 3-year period in a Romanian general hospital. Clin Interv Aging. 2013, 8:999-1005.
30. Tribouilloy C., Rusinaru D., Mahjoub H., Souliere V., Levy F., Peltier M., et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J. 2008, 29(3):339-347.